Volume Spike Investor

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has finally seen its trading volume catch up to its news.  We were baffled this morning about the significant underperformance and low trading volume.  At 10:58 AM EST we have shares up over 18% at $18.72 on over 1.7 million shares.  Average volume is now over 500K and the 52-week trading range is $11.81 to $23.49.  The news is as follows:   Regeneron Pharmaceuticals, Inc. is trading up this morning but on volume that is lighter than expected.  Sanofi-Aventis has expanded its antibody research efforts with Regeneron.  The deal is said to be close to $1 billion all-in: Sanofi-Aventis will increase its annual funding commitment from $100M to $160 million beginning in 2010, and the research funding will now extend through 2017.

JON C. OGG